Cyrus Biotechnology, Inc.

Biotechnology company · Seattle, Washington, United States

Cyrus Biotechnology, Inc. is a biotechnology company headquartered in Seattle, Washington, United States. Its earliest recorded incorporation is in 2014. It has received 3 US government small-business research awards (SBIR/STTR) from health agencies, $823,823 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $1.5 million sold in a notice filed in 2026.

Profile compiled from public records. Is this your company? Request a correction or update

Cyrus Biotechnology at a glance

Typebiotechnology company
HeadquartersSeattle, Washington, United States
Earliest incorporation on record2014
Employees (self-reported, 2025)22
SEC CIK1641241

What does Cyrus Biotechnology do?

US government research funding

3 SBIR/STTR small-business research awards from US health agencies, $823,823 in total (2016 to 2025). NIH funding came from the National Institute of Allergy and Infectious Diseases, National Institute of General Medical Sciences, National Institute of Arthritis and Musculoskeletal and Skin Diseases.

Private fundraising reported to the SEC

7 Form D notices; the most recent reported $1.5 million sold (2026).

Frequently asked questions about Cyrus Biotechnology

Where is Cyrus Biotechnology headquartered?

Cyrus Biotechnology, Inc. is headquartered in Seattle, Washington, United States.

What does Cyrus Biotechnology do?

Cyrus Biotechnology, Inc. is a biotechnology company.

When was Cyrus Biotechnology founded?

The earliest incorporation on record for Cyrus Biotechnology, Inc. is in 2014, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences